The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) and The Dow Chemical Company today announced a research alliance combining AIBN’s research expertise with Dow’s market knowledge.
29 November 2007A Member of
Privacy & Terms of use | Feedback
Authorised by: Director, Office of Marketing and Communications
ABN: 63 942 912 684
CRICOS
Provider No: 00025B